Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study)

NCT00577135 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

308

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Furosemide-Q12 hour bolus
DRUG: Furosemide-Continuous Infusion
DRUG: Furosemide-Low Intensification
DRUG: Furosemide-High Intensification

Sponsor

Duke University

Collaborators

[object Object]